BPA
IDXX icon

Beacon Pointe Advisors’s Idexx Laboratories IDXX Stock Holding History

Beacon Pointe Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Buy
5,862
+5,058
+629% +$3.24M 0.02% 595
2025
Q4 		$544K Buy
804
+178
+28% +$121K ﹤0.01% 1051
2025
Q3 		$400K Sell
626
-39
-6% -$23.7K ﹤0.01% 1090
2025
Q2 		$357K Buy
+665
New +$318K ﹤0.01% 990
2024
Q4 		– Sell
-627
Closed -$317K – 1239
2024
Q3 		$317K Sell
627
-151
-19% -$73.4K ﹤0.01% 1000
2024
Q2 		$379K Sell
778
-14
-2% -$7.03K ﹤0.01% 972
2024
Q1 		$428K Sell
792
-539
-40% -$295K ﹤0.01% 977
2023
Q4 		$739K Sell
1,331
-100
-7% -$46.9K 0.01% 766
2023
Q3 		$626K Buy
1,431
+652
+84% +$325K 0.01% 788
2023
Q2 		$391K Sell
779
-719
-48% -$345K 0.01% 794
2023
Q1 		$749K Buy
1,498
+700
+88% +$335K 0.01% 625
2022
Q4 		$326K Buy
+798
New +$310K 0.01% 837
2022
Q2 		– Sell
-6,094
Closed -$3.33M – 1133
2022
Q1 		$3.33M Buy
6,094
+5,502
+929% +$2.89M 0.05% 332
2021
Q4 		$390K Buy
592
+201
+51% +$126K 0.01% 639
2021
Q3 		$243K Sell
391
-371
-49% -$249K 0.01% 785
2021
Q2 		$481K Buy
+762
New +$421K 0.02% 489

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Beacon Pointe Advisors's IDXX Position: Q1 2026 in Review

Beacon Pointe Advisors increased its Idexx Laboratories (IDXX) stake by 629% in Q1 2026, buying an estimated $3.24M and bringing the position to 5,862 shares worth $3.29M. The position accounts for 0.02% of the portfolio, ranked #595.

Beacon Pointe Advisors first reported a position in IDXX in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.33M in Q1 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Beacon Pointe Advisors held 5,862 shares of Idexx Laboratories worth $3.29M as of Q1 2026.
  • Beacon Pointe Advisors bought 5,058 Idexx Laboratories shares in Q1 2026, an estimated $3.24M.
  • Idexx Laboratories made up 0.02% of Beacon Pointe Advisors's portfolio in Q1 2026, its #595 holding.
  • Beacon Pointe Advisors first reported a position in Idexx Laboratories in Q2 2021 and has held it in 16 quarters since.
  • Beacon Pointe Advisors's Idexx Laboratories position peaked at $3.33M in Q1 2022.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.